Surgical Science Sweden AB (publ) (STO:SUS)

Sweden flag Sweden · Delayed Price · Currency is SEK
153.80
-0.80 (-0.52%)
Jul 4, 2025, 4:59 PM CET
23.63%
Market Cap 7.85B
Revenue (ttm) 946.54M
Net Income (ttm) 141.09M
Shares Out 51.03M
EPS (ttm) 2.76
PE Ratio 55.76
Forward PE 33.29
Dividend n/a
Ex-Dividend Date n/a
Volume 21,789
Average Volume 85,811
Open 154.00
Previous Close 154.60
Day's Range 151.20 - 154.50
52-Week Range 106.40 - 192.40
Beta 0.63
RSI 57.44
Earnings Date Aug 21, 2025

About STO:SUS

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra... [Read more]

Sector Healthcare
Founded 1997
Employees 274
Stock Exchange Nasdaq Stockholm
Ticker Symbol SUS
Full Company Profile

Financial Performance

In 2024, STO:SUS's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.

Financial Statements

News

There is no news available yet.